Publications

<

Year: 2026

Cost-effectiveness analysis of liposomal irinotecan in combination with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas in Greece

Aug 25, 2026

Published on: Expert Review of Pharmacoeconomics & Outcomes Research
Authors: George Gourzoulidis, Vassiliki Chotzagiannoglou, Andriani Angelopoulou, Eleana Solakidou, Charalampos Tzanetakos,

Abstract Objective: To evaluate the cost-effectiveness of liposomal Irinotecan (Onivyde) in combination with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) compared to gemcitabine plus nab-paclitaxel (GemNabPac), for the first-line treatment (FLT) of adult...

Read More

Persistent disease burden despite advanced therapies in inflammatory bowel disease: a real-world patient-reported survey from Greece

Jul 15, 2026

Published on: Frontiers in Immunology
Authors: Charalampos Tzanetakos, Vasiliki-Rafaela Vakouftsi, George Mavridoglou, Andriani Angelopoulou, George Gourzoulidis,

Abstract Objectives: Despite therapeutic advances, inflammatory bowel disease (IBD) remains a lifelong debilitating disorder with substantial burden. The study aimed to investigate disease burden and unmet needs in IBD patients receiving advanced therapies in Greece....

Read More

Editorial: Advancing Health Technology Assessment and patient-reported outcomes: innovations and implications for health economics and outcomes research

Jun 27, 2026

Published on: Frontiers in Public Health
Authors: George Gourzoulidis, Catherine Kastanioti , George Mavridoglou, Theodore Kotsilieris, Charalampos Tzanetakos,

Health Technology Assessment (HTA) has become a central instrument for evidence-informed healthcare decision-making, supporting reimbursement, pricing, prioritization, and resource allocation across health systems facing increasing clinical, economic, and societal...

Read More

Disease burden and unmet medical need in severe hemophilia in Greece: insights from clinicians and patients

Mar 27, 2026

Published on: Frontiers in Public Health
Authors: Nikoletta Sofiaki, Oresteia Zisimopoulou, Argyro Solakidi, Marina Economou , Olga Katsarou , Anna Kouramba, Efrosyni Nomikou, Helen Pergantou, Sofia Vakalopoulou, George Filippidis, Vasilis Grammelis, Damianos Menegas, Andriani Angelopoulou, Charalampos Tzanetakos, George Gourzoulidis,

Abstract Objectives: Hemophilia is the most common severe hereditary bleeding disorder, with significant unmet needs in its management. This study aimed to assess the burden and unmet needs of severe hemophilia in Greece from a clinician and patient perspective....

Read More

Archive per Year